Prograf FDA Approval History
FDA Approved: Yes (First approved April 8, 1994)
Brand name: Prograf
Generic name: tacrolimus
Dosage form: Capsules, Granules for Oral Suspension and Injection
Company: Astellas Pharma US, Inc.
Treatment for: Organ Transplant, Rejection Prophylaxis
Prograf (tacrolimus) is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants.
Development timeline for Prograf
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
